Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer.

Scientific reports - 16 Aug 2023

Li Jiazheng, Yang Chao, Zheng Yongbin

Abstract excerpt

Disulfidptosis is a newly-identified non-programmed cell death mode with tight associations with glucose metabolism. Elevated glycolysis is an important metabolic feature of tumor cells, which fulfills the energy requirement for their rapid growth and progression. Our present study determined to develop a disulfidptosis and glycolysis related gene (DGRG) risk score signature to predict the prognosis and ICI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Disulfides
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glycolysis

Share to Infant

Share to Infant, Newborn

Share to Nomograms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 37587262
DOI: 10.1038/s41598-023-40381-5
PMCID: PMC10432503

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer.PMID 37587262Read ↗

The disulfidptosis-related signature associated with the tumor environment and prognosis of patients with Colon CancerSemantic proximity Read ↗

A novel disulfidptosis-related lncRNA signature in colorectal cancer for predicting prognosis, tumor immune microenvironment features and drug sensitivitySemantic proximity Read ↗

Molecular Subtypes Based on Disulfidptosis-related Genes and Tumor Microenvironment Infiltration Characterization in Hepatocellular CarcinomaSemantic proximity Read ↗

Disulfidptosis-associated Long Non-Coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinomaSemantic proximity Read ↗

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinomaSemantic proximity Read ↗

Personalized Therapies in Hepatocellular Carcinoma: Insights from a Disulfidptosis-Related SignatureSemantic proximity Read ↗

Identification of a disulfidptosis-related genes signature for prognostic implication in ovarian cancerSemantic proximity Read ↗

Identification of Five Glycolysis-Related Gene Signature and Risk Score Model for Colorectal CancerSemantic proximity Read ↗

A disulfidptosis-related LncRNAs index predicting prognosis and tumor microenvironment in colorectal cancerSemantic proximity Read ↗

Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicineSemantic proximity Read ↗

Prognostic implications of metabolism-associated gene signatures in colorectal cancerSemantic proximity Read ↗

A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.